Ann: IDT Executes Manufacturing Agreement With Monash, page-26

Below is a snippet from an article in the SMH business section today.


Dr Sparling said his business wanted to help other mRNA researchers in bringing their products to market in the future too. “There is an awful lot of research being done - IDT sees this as a really good opportunity to step up and assist,” he said.The company is among a range of pharmaceutical producers including CSL that have made pitches to the federal government for establishing an onshore manufacturing facility for mRNA vaccines.The selection process is ongoing, and the government is also in discussions with Moderna about the possibility of it setting up local manufacturing in Australia. IDT shares traded 4.2 per cent higher in early morning trade before settling flat at 59.5 cents by 3:30pm.